Sinopharm applies for vaccine market approval
chinadaily.com.cn |
Updated: 2020-11-25 14:29
Share
Share - WeChat
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.
- Asia's longest tyrannosaur femur fossil identified in East China
- Railway group expresses condolences and vows probe after accident kills 12
- Media center for victory anniversary events to open on Aug 27
- Rabbits and cavies in spotlight at Shanghai Pet Fair Asia
- Over 800m railway journeys made during China's 2025 summer travel rush
- Second round of recall votes targeting Kuomintang lawmakers fails
